Although a decline in insulin requirements during the third trimester has well-established pathophysiological relevance in gestational diabetes mellitus (GDM) where it is often considered a failing fetoplacental unit due to the typically insulin resistant state of late pregnancy [22], it has also been observed in pregnant people with type 1 and type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.